Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Over the past 20 years, the toxicological and protective roles of the placental barrier with respect to drug detoxification and transporter-controlled protection of the fetus have been intensively examined. Several cytochrome P450 enzymes are expressed in placental trophoblast at different stages of pregnancy, though only a few of these have functional activity to metabolize xenobiotics. Drug transporters such as P-glycoprotein/MDR1 or breast cancer resistance protein (BCRP) are highly expressed in the placenta, and their functional activities have been demonstrated in the placenta both in vitro and in vivo. In addition, several studies have reported on ligand-activated transcription factors and nuclear receptors referred to as "xenosensors" in the placenta. The xenosensors control transcriptional regulation of both xenobiotic-metabolizing enzymes and drug transporters in different organs. Their ligands include toxic compounds and environmental pollutants, drugs, as well as herbal, dietary or vitamin supplements. Nevertheless, it remains debatable whether the placental barrier adapts to toxic injuries coming either from maternal medication or environmental contamination and whether the placenta contains a mechanism to respond dynamically in protecting the developing fetus. In the present paper, we summarize current knowledge about the activity and expression of major ligand-activated transcriptional mechanisms involved in biotransformation enzymes and transporters regulation in human placenta. In particular, we highlight the emerging roles of aryl hydrocarbon (AHR), vitamin D (VDR), glucocorticoid (GR) and pregnane X (PXR) receptors in that regulation. We show that the placenta constitute a unique metabolizing organ with significant overlap of exogenous and endogenous compounds metabolism controlled by nuclear receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
The molecular biology of cytochrome P450s
Gonzalez, F. J. (1988) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00021-3 · Cited by 1,301
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Rosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Seckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Cloning and expression of a human Ah receptor cDNA.
Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., & Bradfield, C. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13282-3 · Cited by 348 · cited 1×
“AHR mRNA expression was found in human placenta soon after the discovery of AHR (Dolwick et al., 1993).”
BackgroundNuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288 · cited 2×
“…HIV protease inhibitors (ritonavir, indinavir), dietary compounds (hyperforin, colupulone), bile acids (lithocholic acid), endocrine disruptors (bisphenol A, diethylhexyl phthalate, nonylphenol) and pesticides (chlordane) (Chen et al., 2012; di Masi et al., 2009) are among human PXR ligands.”
BackgroundSun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., & Gibb, W. (2006) · Placenta · doi:10.1016/j.placenta.2005.05.007 · Cited by 223
Dynamic HIF1A Regulation During Human Placental Development1
Ietta, F., Wu, Y., Winter, J., Xu, J., Wang, J., Post, M., & Caniggia, I. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.051557 · Cited by 127
Stejskalova, L., & Pavek, P. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795470994 · Cited by 125
Cited by
Chatuphonprasert, W., Jarukamjorn, K., & Ellinger, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01027 · Cited by 269
The Placental Barrier: the Gate and the Fate in Drug Distribution
Tetro, N., Moushaev, S., Rubinchik-Stern, M., & Eyal, S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2286-0 · Cited by 145
Altered placental DNA methylation patterns associated with maternal smoking: current perspectives
Maccani, J. Z. J., & Maccani, M. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s61518 · Cited by 62
Evaluation potential effects of Picroside II on cytochrome P450 enzymes in vitro and in vivo
Zhou, N., Zhu, Y., Hu, M., Zheng, R., Sun, M., Bian, Y., Chen, X., & Li, T. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116582 · Cited by 5
Metadata
- Authors
- Pavek, P., & Smutny, T.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2013-09-10
- Volume
- 46
- Issue
- 1
- Pages
- 19-32
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2125470170
- Cited by
- 42
- References
- 11
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier. https://app.cochat.ai/papers/10.3109/03602532.2013.835819
- The paper
- Pavek, P., & Smutny, T. (2014). Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier. Drug Metabolism Reviews. https://doi.org/10.3109/03602532.2013.835819
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.